News
BIO
362.08
+1.64%
5.83
Bio-Rad (BIO) Q2 2026 Earnings Call Transcript
The Motley Fool · 1d ago
Bio Rad Laboratories (BIO) Issues Flat Revenue Guidance, Is It Too Far Above Fair Value?
Simply Wall St · 1d ago
Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock
NASDAQ · 2d ago
Weekly Report: what happened at BIO last week (0803-0807)?
Weekly Report · 3d ago
Bio Rad Laboratories (BIO) Stock Looks Priced Above Fair Value
Simply Wall St · 4d ago
Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital
Dow Jones · 5d ago
Bio-Rad Laboratories Price Target Raised to $390.00/Share From $370.00 by RBC Capital
Dow Jones · 5d ago
RBC Capital Maintains Outperform on Bio-Rad Laboratories, Raises Price Target to $390
Benzinga · 5d ago
Bio-Rad price target raised to $390 from $370 at RBC Capital
TipRanks · 6d ago
Bio Rad Laboratories (BIO) Stock Jumps As ddPCR Progress Meets Flat Demand
Simply Wall St · 08/05 22:23
Bio-Rad Laboratories Is Maintained at Neutral by Citigroup
Dow Jones · 08/05 19:04
Bio-Rad Laboratories Price Target Raised to $330.00/Share From $300.00 by Citigroup
Dow Jones · 08/05 19:04
Citigroup Maintains Neutral on Bio-Rad Laboratories, Raises Price Target to $330
Benzinga · 08/05 18:54
Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital
Dow Jones · 08/05 15:56
Bio-Rad Laboratories Price Target Raised to $370.00/Share From $320.00 by RBC Capital
Dow Jones · 08/05 15:56
RBC Capital Maintains Outperform on Bio-Rad Laboratories, Raises Price Target to $370
Benzinga · 08/05 15:46
Bio-Rad Laboratories Price Target Raised to $330.00/Share From $310.00 by Wells Fargo
Dow Jones · 08/05 15:13
Bio-Rad Laboratories Is Maintained at Equal-Weight by Wells Fargo
Dow Jones · 08/05 15:13
Wells Fargo Maintains Equal-Weight on Bio-Rad Laboratories, Raises Price Target to $330
Benzinga · 08/05 15:02
More
Webull provides a variety of real-time BIO stock news. You can receive the latest news about Bio Rad Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.